| Name | Title | Contact Details |
|---|
A WORLD OF STRONGER CONNECTIONS MADE POSSIBLE WITH SECUREG MITRE Engenuity, CTIA-The Wireless Association, and other private investors have formed SecureG…
Cellerant Therapeutics is a clinical stage biotechnology company focused on developing human stem cell and antibody therapies for oncology applications and blood-related disorders. Cellerant`s programs include: CLT-008, an off-the-shelf cellular immunotherapy, under evaluation in a multicenter, open-label, randomized, controlled Phase 2 clinical trial in patients with de novo AML; CSC030-ADC, a preclinical monoclonal antibody drug conjugate that selectively targets and kills leukemic stem and blast cells responsible for initiating and maintaining disease; and CSC012, a preclinical monoclonal antibody targeting leukemic and pre-leukemic stem cells for acute leukemias and myelodysplastic syndromes. The Company is also developing next generation CAR product candidates leveraging its proprietary immunocellular therapy and antibody discovery and development platform.
Esenai Corporation is a Washington, DC-based company in the Business Services sector.
Questionmark Corporation is a Norwalk, CT-based company in the Business Services sector.
Aralia Systems Inc is a New York, NY-based company in the Business Services sector.